Full history for every metric is available with a Kvantra account
Shanghai Eliansy Industry Group Corporation Limited (600836.SS)
Key financial summary
Financials in CNY| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | CNY m | 1,362 | 1,093 | 2,193 | 833 | 514 | 516 | 511 |
| Operating profit | CNY m | -24 | -37 | |||||
| Net profit | CNY m | -12 | -107 | 235 | 207 | -82 | -29 | -39 |
| EPS reported | CNY | -0.04 | -0.06 | |||||
| Operating cashflow per share | CNY | -1.46 | -1.46 | |||||
| Capex per share | CNY | 0.02 | 0.02 | |||||
| FCF per share | CNY | -1.48 | -1.48 | |||||
| Free cash flow | CNY m | -990 | -904 | |||||
| Net debt | CNY m | 466 | 445 | |||||
| Book value equity | CNY m | 1,116 | 1,108 | |||||
| Book value per share | CNY | 1.67 | 1.65 | |||||
| Number of shares | m | 670.55 | 670.06 | |||||
| DPS (TTM paid) | CNY | 0.04 | 0.00 |
Financial summary
Financials in CNY| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 2.53 | 0.27 | |||||
| P/S LTM | x | 5.47 | 0.59 | |||||
| P/FCF LTM | x | -2.85 | -0.33 | |||||
| EV/EBITDA LTM | x | 72.26 | 32.73 | |||||
| EV/Sales LTM | x | 6.37 | 1.46 | |||||
| Earnings Yield LTM | % | -1.02% | -9.53% | |||||
| FCF Yield | % | -35.08% | -301.82% | |||||
| Quality | ||||||||
| ROE | % | -2.58% | -2.54% | |||||
| ROIC | % | -1.42% | -1.42% | |||||
| Operating margin | % | -4.61% | -4.61% | |||||
| Gross margin | % | 18.07% | 18.07% | |||||
| FCF/Sales | % | -191.88% | -191.88% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +0.34% | +2.52% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.99% | 0.00% | |||||
| Dividend Growth | % | - | - | |||||
| Payout Ratio | % | -97.36% | -73.94% | |||||
| FCF/Debt | x | -1.89 | -1.79 | |||||
| Net Debt/EBITDA | x | 10.24 | 10.24 | |||||
| EBIT/Net interest | x | -0.83 | -0.83 | |||||
| Net debt/market cap | % | 16.52% | 148.53% | |||||
| Net debt/Equity | x | 0.42 | 0.40 | |||||
| Gross debt/equity | x | 0.47 | 0.46 | |||||
Company overview
Shanghai Eliansy Industry Group Corporation Limited, headquartered in Shanghai, China, operates a diverse business portfolio both domestically and globally. Its primary activities include printing services, encompassing environmentally friendly printing and paper distribution, alongside a comprehensive range of medical services. Within the medical sector, the company provides training systems, deals in traditional Chinese medicine, supplies pharmaceuticals, and manages an online hospital specializing in chronic illness and cancer recovery. It also oversees a medical health industrial park. Beyond these core areas, the group is involved in real estate development, particularly urban nursing home initiatives. Furthermore, it strategically invests in emerging sectors such as biomedicine, medical equipment, and general health; information technology and artificial intelligence; and new materials, energy conservation, and environmental protection. This entity was formerly known as Shanghai Jielong Industry Group Corporation Limited.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Shanghai Eliansy Industry Group Corporation Limited (600836.SS)
Shanghai Eliansy Industry Group Corporation Limited, headquartered in Shanghai, China, operates a diverse business portfolio both domestically and globally. Its primary activities include printing services, encompassing environmentally friendly printing and paper distribution, alongside a comprehensive range of medical services. Within the medical sector, the company provides training systems, deals in traditional Chinese medicine, supplies pharmaceuticals, and manages an online hospital specializing in chronic illness and cancer recovery. It also oversees a medical health industrial park. Beyond these core areas, the group is involved in real estate development, particularly urban nursing home initiatives. Furthermore, it strategically invests in emerging sectors such as biomedicine, medical equipment, and general health; information technology and artificial intelligence; and new materials, energy conservation, and environmental protection. This entity was formerly known as Shanghai Jielong Industry Group Corporation Limited.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free